M Cemazar, C S Parkins, A L Holder, D J Chaplin, G M Tozer: Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. In: British Journal of Cancer. Band84, Nr.4, 15. Februar 2001, S.565–570, doi:10.1054/bjoc.2000.1625, PMID 11207055, PMC 2363761 (freier Volltext).
Gregor Serša, Maja Čemažar, Bostjan Markelc: Blood Flow Modifying and Vascular-Disrupting Effects of Electroporation and Electrochemotherapy. In: Handbook of Electroporation. Springer International Publishing, Cham 2017, ISBN 978-3-319-32886-7, S.691–705, doi:10.1007/978-3-319-32886-7_165.
W. A. Wohlgemuth, R. Müller-Wille u. a.: Bleomycin ElectroScleroTherapy (BEST) in therapy-resistant venous malformations of the body. In: Journal of vascular surgery. Venous and lymphatic disorders. [elektronische Veröffentlichung vor dem Druck] Oktober 2020, doi:10.1016/j.jvsv.2020.09.009, PMID 33045393.
nih.gov
ncbi.nlm.nih.gov
M Cemazar, C S Parkins, A L Holder, D J Chaplin, G M Tozer: Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. In: British Journal of Cancer. Band84, Nr.4, 15. Februar 2001, S.565–570, doi:10.1054/bjoc.2000.1625, PMID 11207055, PMC 2363761 (freier Volltext).
W. A. Wohlgemuth, R. Müller-Wille u. a.: Bleomycin ElectroScleroTherapy (BEST) in therapy-resistant venous malformations of the body. In: Journal of vascular surgery. Venous and lymphatic disorders. [elektronische Veröffentlichung vor dem Druck] Oktober 2020, doi:10.1016/j.jvsv.2020.09.009, PMID 33045393.
